Baudax Intangible Assets vs Total Liab Analysis

BXRX Stock

USD 0.01 0.0006 5.66%

Baudax BioInc financial indicator trend analysis is way more than just evaluating Baudax BioInc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Baudax BioInc is a good investment. Please check the relationship between Baudax BioInc Intangible Assets and its Total Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Intangible Assets vs Total Liab

Intangible Assets vs Total Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Baudax BioInc Intangible Assets account and Total Liab. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Baudax BioInc's Intangible Assets and Total Liab is 0.91. Overlapping area represents the amount of variation of Intangible Assets that can explain the historical movement of Total Liab in the same time period over historical financial statements of Baudax BioInc, assuming nothing else is changed. The correlation between historical values of Baudax BioInc's Intangible Assets and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Intangible Assets of Baudax BioInc are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Intangible Assets i.e., Baudax BioInc's Intangible Assets and Total Liab go up and down completely randomly.

Correlation Coefficient

0.91

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Intangible Assets

Non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value.

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Most indicators from Baudax BioInc's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Baudax BioInc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Selling General Administrative is likely to rise to about 22.7 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 9.1 M in 2024.

	2021	2022	2023	2024 (projected)
Reconciled Depreciation	2.8M	2.2M	2.3M	1.7M
Total Operating Expenses	51.0M	30.0M	36.3M	38.0M

Reconciled Depreciation Total Operating Expenses

Baudax BioInc fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Good Will	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Non Current Liabilities Other	Net Working Capital	Intangible Assets	Common Stock	Property Plant Equipment	Short Long Term Debt Total	Current Deferred Revenue	Net Debt
Total Assets		-0.06	-0.14	0.27	0.57	-0.02	0.91	-0.19	0.79	0.17	0.57	-0.75	0.65	0.82	-0.26	0.33	0.89	0.7	0.57	0.47	0.44	0.03	0.89	-0.02	-0.3	-0.7
Other Current Liab	-0.06		0.99	-0.85	0.42	-0.88	-0.41	0.95	0.49	0.71	0.39	-0.55	0.36	0.48	-0.84	0.78	-0.41	-0.66	0.42	-0.9	0.71	-0.92	-0.41	-0.75	-0.73	-0.59
Total Current Liabilities	-0.14	0.99		-0.83	0.33	-0.84	-0.5	0.98	0.39	0.64	0.37	-0.46	0.26	0.4	-0.77	0.7	-0.5	-0.68	0.32	-0.92	0.64	-0.88	-0.5	-0.69	-0.64	-0.5
Total Stockholder Equity	0.27	-0.85	-0.83		-0.55	0.95	0.48	-0.8	-0.33	-0.77	-0.24	0.35	-0.47	-0.33	0.82	-0.8	0.54	0.8	-0.55	0.89	-0.69	0.93	0.47	0.82	0.75	0.5
Other Liab	0.57	0.42	0.33	-0.55		-0.73	0.46	0.24	0.85	0.79	0.61	-0.81	0.99	0.85	-0.82	0.86	0.37	-0.06	1.0	-0.18	0.89	-0.63	0.46	-0.69	-0.84	-0.91
Net Tangible Assets	-0.02	-0.88	-0.84	0.95	-0.73		0.23	-0.77	-0.59	-0.88	-0.43	0.61	-0.66	-0.58	0.95	-0.92	0.28	0.65	-0.73	0.8	-0.86	0.97	0.22	0.89	0.88	0.72
Property Plant And Equipment Net	0.91	-0.41	-0.5	0.48	0.46	0.23		-0.56	0.58	0.0	0.4	-0.52	0.54	0.57	-0.01	0.07	0.98	0.79	0.46	0.72	0.2	0.28	1.0	0.15	-0.08	-0.44
Accounts Payable	-0.19	0.95	0.98	-0.8	0.24	-0.77	-0.56		0.28	0.52	0.33	-0.35	0.19	0.34	-0.68	0.63	-0.57	-0.63	0.24	-0.89	0.55	-0.8	-0.57	-0.57	-0.54	-0.44
Non Current Assets Total	0.79	0.49	0.39	-0.33	0.85	-0.59	0.58	0.28		0.71	0.74	-0.99	0.86	0.95	-0.79	0.76	0.57	0.11	0.85	-0.13	0.86	-0.57	0.59	-0.6	-0.77	-0.95
Non Currrent Assets Other	0.17	0.71	0.64	-0.77	0.79	-0.88	0.0	0.52	0.71		0.52	-0.7	0.72	0.59	-0.95	0.83	-0.05	-0.54	0.79	-0.61	0.92	-0.84	0.04	-0.99	-0.94	-0.75
Good Will	0.57	0.39	0.37	-0.24	0.61	-0.43	0.4	0.33	0.74	0.52		-0.79	0.62	0.72	-0.63	0.46	0.38	0.04	0.61	-0.13	0.71	-0.45	0.41	-0.45	-0.48	-0.7
Common Stock Shares Outstanding	-0.75	-0.55	-0.46	0.35	-0.81	0.61	-0.52	-0.35	-0.99	-0.7	-0.79		-0.82	-0.94	0.8	-0.75	-0.52	-0.06	-0.81	0.19	-0.86	0.61	-0.54	0.61	0.75	0.94
Non Current Liabilities Total	0.65	0.36	0.26	-0.47	0.99	-0.66	0.54	0.19	0.86	0.72	0.62	-0.82		0.88	-0.77	0.83	0.45	0.05	0.99	-0.09	0.86	-0.56	0.54	-0.61	-0.79	-0.92
Other Current Assets	0.82	0.48	0.4	-0.33	0.85	-0.58	0.57	0.34	0.95	0.59	0.72	-0.94	0.88		-0.73	0.79	0.53	0.22	0.85	-0.09	0.82	-0.52	0.56	-0.47	-0.72	-0.97
Other Stockholder Equity	-0.26	-0.84	-0.77	0.82	-0.82	0.95	-0.01	-0.68	-0.79	-0.95	-0.63	0.8	-0.77	-0.73		-0.93	0.03	0.49	-0.82	0.67	-0.96	0.93	-0.03	0.92	0.94	0.85
Total Liab	0.33	0.78	0.7	-0.8	0.86	-0.92	0.07	0.63	0.76	0.83	0.46	-0.75	0.83	0.79	-0.93		0.01	-0.35	0.86	-0.56	0.91	-0.86	0.07	-0.79	-0.94	-0.88
Property Plant And Equipment Gross	0.89	-0.41	-0.5	0.54	0.37	0.28	0.98	-0.57	0.57	-0.05	0.38	-0.52	0.45	0.53	0.03	0.01		0.78	0.37	0.72	0.14	0.3	0.99	0.19	-0.02	-0.39
Total Current Assets	0.7	-0.66	-0.68	0.8	-0.06	0.65	0.79	-0.63	0.11	-0.54	0.04	-0.06	0.05	0.22	0.49	-0.35	0.78		-0.06	0.9	-0.29	0.71	0.75	0.66	0.39	-0.03
Non Current Liabilities Other	0.57	0.42	0.32	-0.55	1.0	-0.73	0.46	0.24	0.85	0.79	0.61	-0.81	0.99	0.85	-0.82	0.86	0.37	-0.06		-0.18	0.89	-0.63	0.46	-0.69	-0.84	-0.91
Net Working Capital	0.47	-0.9	-0.92	0.89	-0.18	0.8	0.72	-0.89	-0.13	-0.61	-0.13	0.19	-0.09	-0.09	0.67	-0.56	0.72	0.9	-0.18		-0.48	0.85	0.71	0.7	0.54	0.25
Intangible Assets	0.44	0.71	0.64	-0.69	0.89	-0.86	0.2	0.55	0.86	0.92	0.71	-0.86	0.86	0.82	-0.96	0.91	0.14	-0.29	0.89	-0.48		-0.8	0.21	-0.87	-0.95	-0.92
Common Stock	0.03	-0.92	-0.88	0.93	-0.63	0.97	0.28	-0.8	-0.57	-0.84	-0.45	0.61	-0.56	-0.52	0.93	-0.86	0.3	0.71	-0.63	0.85	-0.8		0.27	0.86	0.81	0.65
Property Plant Equipment	0.89	-0.41	-0.5	0.47	0.46	0.22	1.0	-0.57	0.59	0.04	0.41	-0.54	0.54	0.56	-0.03	0.07	0.99	0.75	0.46	0.71	0.21	0.27		0.11	-0.1	-0.44
Short Long Term Debt Total	-0.02	-0.75	-0.69	0.82	-0.69	0.89	0.15	-0.57	-0.6	-0.99	-0.45	0.61	-0.61	-0.47	0.92	-0.79	0.19	0.66	-0.69	0.7	-0.87	0.86	0.11		0.91	0.65
Current Deferred Revenue	-0.3	-0.73	-0.64	0.75	-0.84	0.88	-0.08	-0.54	-0.77	-0.94	-0.48	0.75	-0.79	-0.72	0.94	-0.94	-0.02	0.39	-0.84	0.54	-0.95	0.81	-0.1	0.91		0.85
Net Debt	-0.7	-0.59	-0.5	0.5	-0.91	0.72	-0.44	-0.44	-0.95	-0.75	-0.7	0.94	-0.92	-0.97	0.85	-0.88	-0.39	-0.03	-0.91	0.25	-0.92	0.65	-0.44	0.65	0.85

Click cells to compare fundamentals

Baudax BioInc Account Relationship Matchups

Baudax BioInc fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	54.2M	68.7M	53.3M	10.0M	9.0M	8.6M
Other Current Liab	7.1M	13.5M	12.0M	11.9M	10.7M	13.6M
Total Current Liabilities	7.7M	18.1M	15.6M	21.5M	19.3M	17.4M
Total Stockholder Equity	(16.7M)	(14.8M)	13.2M	(24.2M)	(27.9M)	(29.3M)
Other Liab	62.8M	56.6M	18.1M	10.7M	9.6M	9.1M
Net Tangible Assets	(45.2M)	(41.2M)	(10.6M)	(26.4M)	(30.3M)	(31.8M)
Property Plant And Equipment Net	5.6M	5.6M	5.0M	704K	633.6K	601.9K
Accounts Payable	271K	3.7M	1.5M	3.9M	3.5M	2.6M
Non Current Assets Total	34.1M	32.0M	29.8M	3.7M	3.3M	3.2M
Non Currrent Assets Other	34.1M	583K	963K	854K	768.6K	730.2K
Liabilities And Stockholders Equity	54.2M	68.7M	53.3M	10.0M	9.0M	8.6M
Non Current Liabilities Total	63.2M	65.4M	24.4M	12.8M	11.5M	11.0M
Other Current Assets	2.4M	3.3M	2.1M	753K	677.7K	643.8K
Other Stockholder Equity	20.2M	98.3M	144.3M	166.6M	191.6M	201.2M
Total Liab	70.9M	83.5M	40.1M	34.3M	30.8M	57.0M
Property Plant And Equipment Gross	5.6M	5.6M	6.5M	472K	542.8K	515.7K
Total Current Assets	20.1M	36.7M	23.5M	6.3M	7.3M	6.9M
Non Current Liabilities Other	62.8M	56.9M	18.1M	11.3M	10.2M	9.7M
Net Working Capital	12.4M	18.6M	7.8M	(15.1M)	(17.4M)	(16.5M)
Common Stock	94K	487K	983K	16K	18.4K	19.3K
Property Plant Equipment	5.6M	5.1M	5.0M	704K	633.6K	601.9K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
CRM	Salesforce
MSFT	Microsoft

When determining whether Baudax BioInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Baudax BioInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Baudax Bioinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Baudax Bioinc Stock:

How To Invest In Baudax

Details

Is Baudax Stock a good investment?

Details

What is Baudax BioInc's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Complementary Tools for Baudax Stock analysis

When running Baudax BioInc's price analysis, check to measure Baudax BioInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Baudax BioInc is operating at the current time. Most of Baudax BioInc's value examination focuses on studying past and present price action to predict the probability of Baudax BioInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Baudax BioInc's price. Additionally, you may evaluate how the addition of Baudax BioInc to your portfolios can decrease your overall portfolio volatility.

	My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	Technical Analysis Check basic technical indicators and analysis based on most latest market data
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Fundamental Analysis View fundamental data based on most recent published financial statements
	CEOs Directory Screen CEOs from public companies around the world
	Commodity Channel Use Commodity Channel Index to analyze current equity momentum
	Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation

Is Baudax BioInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Baudax BioInc. If investors know Baudax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Baudax BioInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(94.13)

Revenue Per Share

0.318

Quarterly Revenue Growth

(0.23)

Return On Assets

(1.15)

Return On Equity

(47.04)

The market value of Baudax BioInc is measured differently than its book value, which is the value of Baudax that is recorded on the company's balance sheet. Investors also form their own opinion of Baudax BioInc's value that differs from its market value or its book value, called intrinsic value, which is Baudax BioInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Baudax BioInc's market value can be influenced by many factors that don't directly affect Baudax BioInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Baudax BioInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Baudax BioInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Baudax BioInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Baudax Intangible Assets vs Total Liab Analysis

Intangible Assets vs Total Liab

Intangible Assets vs Total Liab Correlation Analysis

Correlation Coefficient

Intangible Assets

Total Liab

Baudax BioInc fundamental ratios Correlations

Baudax BioInc Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Baudax BioInc fundamental ratios Accounts

Also Currently Popular

Complementary Tools for Baudax Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Liabilities Other	+ 1.0	Other Liab
Property Plant Equipment	+ 1.0	Property Plant And Equipment Net
Total Current Liabilities	+ 0.99	Other Current Liab
Non Current Liabilities Total	+ 0.99	Other Liab
Non Current Liabilities Other	+ 0.99	Non Current Liabilities Total
Property Plant Equipment	+ 0.99	Property Plant And Equipment Gross

Short Long Term Debt Total	- 0.99	Non Currrent Assets Other
Common Stock Shares Outstanding	- 0.99	Non Current Assets Total
Net Debt	- 0.97	Other Current Assets
Intangible Assets	- 0.96	Other Stockholder Equity
Current Deferred Revenue	- 0.95	Intangible Assets
Other Stockholder Equity	- 0.95	Non Currrent Assets Other